Jiangsu GQ Pharma

Jiangsu GQ Pharmaceutical Co., Ltd. is a pharmaceutical company based in Taizhou, China, specializing in the development and production of high-end generic and innovative small molecule drugs. Founded in 2014, the company has established a strong presence in the antiviral sector, particularly in the treatment of chronic Hepatitis B, with products like Tenofovir Alafenamide and Entecavir. Beyond antivirals, Jiangsu GQ Pharma focuses on cardiovascular, central nervous system, and oncology therapeutic areas. The company operates a comprehensive R&D center and GMP-certified manufacturing facilities within the China Medical City (CMC) zone. Its business model integrates the entire value chain from API synthesis to finished dosage form production. The company is actively advancing a pipeline of Class 1 innovative drugs to address unmet medical needs in its core therapeutic areas.